Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lymphoma, Non-Hodgkin × efavirenz × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Lymphoma, Non-Hodgkin 1 Lymphoma, AIDS-Related 1 HIV Infections 1 Dendritic Cell Sarcoma, Interdigitating 1 B-cell Tumors 1

Interventions

Rituximab 342 Cyclophosphamide 314 fludarabine phosphate 141 Etoposide 139 Peripheral Blood Stem Cell Transplantation 124 Filgrastim 112 fludarabine 110 Melphalan 98 Mycophenolic Acid 97 Whole-Body Irradiation 89 Vincristine 89 Busulfan 86 Cytarabine 85 Doxorubicin 78 Cyclosporine 75 Tacrolimus 74 Radiotherapy 74 Prednisone 73 Bendamustine Hydrochloride 71 Granulocyte Colony-Stimulating Factor 66 Methotrexate 65 Antilymphocyte Serum 56 Carmustine 54 Dexamethasone 49 Gemcitabine 47 Lenalidomide 46 Bortezomib 43 venetoclax 41 ibritumomab tiuxetan 37 obinutuzumab 36

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01878890 2021-01-27

ESCALE

Institut Bergonié

Phase 1 Completed

25 enrolled 11 charts

Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡